Patent · US Active

Intergenic regions as novel sites for insertion of HIV DNA sequences in the genome of Modified Vaccinia virus Ankara

US7501127B2 · kind B2 · utility

17Cited by

3References

19Claims

0Family size

Assignee

Bavarian Nordic A/S · DK

Inventors

Paul Howley · Scone, AU
Sonja Leyrer · Munich, DE
Paul Chaplin · Munich, DE
Eva Felder · Munich, DE

Key dates

Filing date	Feb 17, 2006
Grant date	Mar 10, 2009
Priority date	—
Expiry date	Feb 5, 2027

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to novel insertion sites useful for the integration of HIV DNA sequences into the MVA genome, and to the resulting recombinant MVA derivatives.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.